Neurology

Latest News

Semaglutide Use Increases Risk of Optic Neuropathy
Semaglutide Use Increases Risk of Optic Neuropathy

July 8th 2024

Researchers addressed the association between semaglutide use and the risk of nonarteritic anterior ischemic optic neuropathy.

FDA Approves Donanemab (Kisunla) For Early Symptomatic Alzheimer Disease
FDA Approves Donanemab (Kisunla) For Early Symptomatic Alzheimer Disease

July 2nd 2024

Q&A: Expert Talks Migraine Myths, Resources for Migraine Awareness
Q&A: Expert Talks Migraine Myths, Resources for Migraine Awareness

June 20th 2024

Navigating Pediatric ADHD Medication Shortages
Navigating Pediatric ADHD Medication Shortages

March 21st 2024

Lecanemab-irmb Approved for Alzheimer Disease
Lecanemab-irmb Approved for Alzheimer Disease

February 22nd 2024

Video Interviews
Latest CME Events & Activities

Navigating Parkinson Disease: Innovative Approaches to Mitigate OFF Episodes

July 24, 2024 | 1:00 PM & 7:00 PM ET

View More

The Role of the Specialty Pharmacist in Optimizing Treatment for Amyotrophic Lateral Sclerosis: The Impact of ...

July 31, 2024 | 1:00 PM & 8:00 PM ET

View More

Improving Outcomes and Quality of Care in Spinal Muscular Atrophy: Updates in Treatment Advances

2.0 Credits / Neurology

View More

Navigating the Use of Targeted Therapies and Individualizing Care for Patients With Ulcerative Colitis

1.5 Credits / Gastroenterology

View More

New and Emerging Treatment Strategies for Myasthenia Gravis: The Role of the Specialty Pharmacist

1.0 Credit / Neurology

View More

Improving Treatment Access for Spinal Muscular Atrophy: How Managed Care Strategies Can Ease Clinical and Care...

1.5 Credits / Neurology

View More

Assessing the Treatment Landscape for Multiple Sclerosis to Better Individualize Care

1.5 Credits / Neurology

View More

Advances in Pharmacotherapy for Excessive Daytime Sleepiness Due to Narcolepsy

2.0 Credits / Neurology

View More

The Role of Long-Term Care and Consultant Pharmacists in the Management of Tardive Dyskinesia

1.0 Credit / Neurology

View More

Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment

1.5 Credits / Cardiology, Neurology, Rare Diseases

View More

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

View More

Exploring Therapeutic Advances for Bipolar Disorder With Mixed Features and Anxious Distress: An Update for Ph...

2.0 Credits / Neurology, Psychiatry

View More

Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis

1.0 Credit / Immunology, Neurology

View More

More News

© 2024 MJH Life Sciences

All rights reserved.